Cases 11 - 20 of 861
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AZURITY PHARMACEUTICALS, INC. v. AUROBINDO PHARMA LTD. et al
as 2:2023cv23273
Plaintiff:
AZURITY PHARMACEUTICALS, INC.
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
MONTALBANO et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22904
Plaintiff:
ANNETTE MONTALBANO and PATRICK MONTALBANO
Defendant:
JOHN DOES 1-50, AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22452
Plaintiff:
BOBBY WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2023cv01193
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Counter Claimant:
Eugia Pharma Specialities Ltd.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GREENE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22298
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
NATHANIEL GREENE
Defendant:
AUROBINDO PHARMA, LTD., SCIEGEN PHARMACEUTICALS, INC., U.S., WESTMINSTER PHARMACEUTICALS and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff:
MARK MCNALL
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff:
ANTHONY IVERS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee:
MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
